Therapy for Progressive and/or Refractory Hematologic Malignancies
Clinical trial NCT02223312 · WITHDRAWN
Trial details
- NCT number
- NCT02223312
- Sponsor
- Kiromic BioPharma Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2018-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.